AEROBIKA® OPEP device
AEROCHAMBER PLUS®️ FLOW-VU®️
Harborview Medical Center Study -AeroEclipse II® BAN - Reduction of 30 day re-admission rate and COPD LOS
Under-dosing of inhaled medication delivered by continuous nebulizers is possible as the result of changes to the Inspiratory/Expiratory (I/E) ratio.
Chesapeake AeroEclipse II® BAN Efficiency Study
Why does device quality matter? See what our customers have to say about AEROECLIPSE® Nebulizer.